249 related articles for article (PubMed ID: 35008527)
1. The Impact of Iron Chelators on the Biology of Cancer Stem Cells.
Szymonik J; Wala K; Górnicki T; Saczko J; Pencakowski B; Kulbacka J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008527
[TBL] [Abstract][Full Text] [Related]
2. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Narusaka T; Ohara T; Noma K; Nishiwaki N; Katsura Y; Kato T; Sato H; Tomono Y; Kikuchi S; Tazawa H; Shirakawa Y; Matsukawa A; Fujiwara T
Int J Cancer; 2021 Jul; 149(2):347-357. PubMed ID: 33662150
[TBL] [Abstract][Full Text] [Related]
3. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
[TBL] [Abstract][Full Text] [Related]
4. A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
Chen Y; Ohara T; Xing B; Qi J; Noma K; Matsukawa A
Acta Med Okayama; 2020 Feb; 74(1):1-6. PubMed ID: 32099242
[TBL] [Abstract][Full Text] [Related]
5. Iron depletion is a novel therapeutic strategy to target cancer stem cells.
Ninomiya T; Ohara T; Noma K; Katsura Y; Katsube R; Kashima H; Kato T; Tomono Y; Tazawa H; Kagawa S; Shirakawa Y; Kimura F; Chen L; Kasai T; Seno M; Matsukawa A; Fujiwara T
Oncotarget; 2017 Nov; 8(58):98405-98416. PubMed ID: 29228699
[TBL] [Abstract][Full Text] [Related]
6. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
8. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
9. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment.
Wang L; Li X; Mu Y; Lu C; Tang S; Lu K; Qiu X; Wei A; Cheng Y; Wei W
J Trace Elem Med Biol; 2019 Dec; 56():131-138. PubMed ID: 31466045
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer.
Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR
J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869
[TBL] [Abstract][Full Text] [Related]
11. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
12. Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.
Ford SJ; Obeidy P; Lovejoy DB; Bedford M; Nichols L; Chadwick C; Tucker O; Lui GY; Kalinowski DS; Jansson PJ; Iqbal TH; Alderson D; Richardson DR; Tselepis C
Br J Pharmacol; 2013 Mar; 168(6):1316-28. PubMed ID: 23126308
[TBL] [Abstract][Full Text] [Related]
13. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer.
Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
[TBL] [Abstract][Full Text] [Related]
15. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
16. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
17. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
18. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
19. Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells.
Ali MS; Gill KS; Saglio G; Cilloni D; Soden DM; Forde PF
Bioelectrochemistry; 2018 Aug; 122():84-92. PubMed ID: 29574322
[TBL] [Abstract][Full Text] [Related]
20. α-Actinin-4 regulates cancer stem cell properties and chemoresistance in cervical cancer.
Jung J; Kim S; An HT; Ko J
Carcinogenesis; 2020 Jul; 41(7):940-949. PubMed ID: 31584624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]